You are currently viewing a new version of our website. To view the old version click .
Diagnostics
  • Correction
  • Open Access

18 February 2022

Correction: Ferraz-Amaro et al. SCORE2 Assessment in The Calculation of Cardiovascular Risk in Patients with Rheumatoid Arthritis. Diagnostics 2021, 11, 2363

,
,
,
,
,
,
,
,
and
1
Division of Rheumatology, Hospital Universitario de Canarias, 38320 Tenerife, Spain
2
Internal Medicine Department, University of La Laguna, 38071 Tenerife, Spain
3
Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, Universidad de Cantabria, 39008 Santander, Spain
4
Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Hospital Universitario Marqués de Valdecilla, IDIVAL, 39011 Santander, Spain
This article belongs to the Special Issue Diagnosis of Rheumatoid Arthritis
In the original article [1], there was a mistake in Figure 1 as published. Due to an error in the proofreading stage, ROC curves in that figure do not represent the exact curves. The corrected Figure 1 appears below. The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. The original publication has also been updated.
Figure 1. Relationship of SCORE and SCORE2 with cIMT and carotid plaque.

Reference

  1. Ferraz-Amaro, I.; Corrales, A.; Atienza-Mateo, B.; Vegas-Revenga, N.; Prieto-Peña, D.; Sánchez-Martín, J.; Almeida, C.; Quevedo-Abeledo, J.C.; Blanco, R.; González-Gay, M.Á. SCORE2 Assessment in the Calculation of Cardiovascular Risk in Patients with Rheumatoid Arthritis. Diagnostics 2021, 11, 2363. [Google Scholar] [CrossRef] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.